Altogether, those studies show the AhR controls cell proliferation of progenitor cells, but also tumor cells and might represent a future therapeutic target for a large pathological spectrum from neurodegenerative diseases to brain cancers. This evidence concerns the gene AHR and neurodegenerative disease.